title: [Can the progression of arteriosclerosis be influenced pharmaco- logically?].
authors.forename: G
authors.initials: G
authors.lastname: Rudofsky
authors.forename: H
authors.initials: H
authors.lastname: Hirche
authors.forename: A
authors.initials: A
authors.lastname: Drück
authors.forename: B
authors.initials: B
authors.lastname: Altenhoff
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001158:Arteries / Q000473:pathology; D001161:Arteriosclerosis / Q000473:pathology / Q000517:prevention & control*; D001241:Aspirin / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D005663:Furans / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009257:Nafronyl / Q000627:therapeutic use*; D011897:Random Allocation; D012307:Risk Factors; D014463:Ultrasonography
chemical_list: D005663:Furans; D009257:Nafronyl; D001241:Aspirin
vernacular_title: Lässt sich die Progression der Arteriosklerose pharmakologisch beeinflussen?